Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 4/20 | 0.39 |
| ▸ | CTSL | P07711 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 5/20 | 0.38 |
| ▸ | CTSB | P07858 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22651659 | 0.91 | PPARA (0.41) | CTSSCTSLALDH1A1PPARACTSK | |
| SCHEMBL18256483 | 0.89 | CTSS (0.42) | CTSSCTSLMEN1KMT2AALDH1A1 | |
| SCHEMBL21266672 | 0.84 | CTSK (0.43) | CTSSCTSLALDH1A1CTSKCTSB | |
| SCHEMBL18256500 | 0.83 | CTSS (0.50) | CTSSCTSLALDH1A1PPARACTSK | |
| SCHEMBL18248047 | 0.83 | CTSS (0.50) | CTSSCTSLALDH1A1PPARACTSK | |
| SCHEMBL21266681 | 0.82 | CTSK (0.42) | CTSSCTSLALDH1A1CTSKCTSB | |
| Hydrochloric Acid SCHEMBL23269876 | 0.82 | CTSS (0.49) | CTSSCTSLALDH1A1PPARACTSK | |
| Hydrochloric Acid SCHEMBL31560870 | 0.82 | CTSS (0.49) | CTSSCTSLALDH1A1PPARACTSK | |
| SCHEMBL23269880 | 0.80 | CTSK (0.53) | CTSSCTSLCTSKCTSB | |
| SCHEMBL18248005 | 0.80 | CTSK (0.53) | CTSSCTSLCTSKCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354408-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | Boehringer Ingelheim Animal Health USA Inc. (US) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354408-A1 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | VIP, PREP, DNPEP | CTSS 245/4885CTSL 86/4885MEN1 1902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.